3Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor [J]. Nature, 1986, 320:454-456.
4Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension [J]. Hypertension, 1993, 21(6 Pt 2):929.
5Panza JA, Garcia CE, Kilcoyne CM, et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduc-tion pathway [J].Circulation, 1995, 91(6):1 732-1 738.
6Taddei S, Virdis A, Mattei P, et al. Aging and en-dothelial function in normoten-sive subjects and patients with essential hypertensive patients [J]. Circulation, 1995, 91(7):1 981-1 987.
7Panza JA, Casino PR, Badar CM, et al. Effect of increased vailability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension [J]. Circulation, 1993, 87(5):1 475-1 481.
8Taddei S, Virdis A, Mattei P, et al. Hypertension ca-uses premature aging of endothelial function in humans [J]. Hypertension, 1997, 29(3):736-743.
9Taddei S, Virdis A, Ghiadoni L, et al. Cyclooxygenase inhibition restores nitric oxide activity in essential hyper-tension [J]. Hypertension, 1997, 29(1 Pt 2):274.
10Ting HH, Timini FK, Boles KS, et al. Vitamin C imp-roves endothelium dependent vasodilation in patients with non-insulin-dependent diabetes mellitus [J]. J Clin Invest, 1996, 97(1):22-28.
2Vecchione C, Colella S, Fratta L, et al. Impaired insulin- like growth factor 1 vasorelaxant effects in hypertension[J ]. Hypertension, 2001, 37(6) : 1480 - 1450.
3Sesti G, Sciaequa A, Scozzafava A, et al. Effects of growth hormone and insulin- like growth factor - 1 on cardiac hypertrophy of hypertensive patients[J]. Hypertensions, 2007,25(2) :471 - 477.
4Tore L. Insulin resistance in hypertension is associated with body fat rather than blood pressure[J ]. Hypertension, 1998,32 (1) : 115.
5Standley PR, Stanley MA, Senechal P, et al. Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth mus- cle[J]. Am J Physiol Endocrinol Metab, 2001,281(6) :1165 - 1171.
6Frystyk, Jan MD, PhD, et al. Cardiovascular disease and insulin - like growth factor 1 [ J ]. American Heart Association, 2002,106 (8) : 893 - 895.
7Onder G, Liperoti R, Russo A, et al. Use of ACE inhibitors is associated with elevated levels of IGFBP - 3 among hypertensive older adults: re- suits from the ILSIRENTE study [ J ]. Eur J Clin Pharmaeol, 2007,63(4):389 - 395.
